Reference Standards Laboratory, Department of Pathology, Children's Hospital of Wisconsin, Milwaukee, WI 53226, USA.
Arch Pathol Lab Med. 2013 Jul;137(7):912-20. doi: 10.5858/arpa.2012-0152-CP.
Discrepant results for serum constituents were observed among peer groups in the College of American Pathologists Comprehensive Chemistry Survey.
To assess the performance of serum albumin and total protein measurement procedures and to evaluate the commutability of the conventional survey specimens.
A fresh frozen, off-the-clot serum sample was included along with 4 conventional survey specimens. The fresh frozen, off-the-clot serum sample was prepared in a manner expected to confer commutability with native clinical samples.
For the fresh frozen, off-the-clot serum sample, the mean values for 17 peer-groups were -0.07 to 0.32 g/dL from the bromocresol green albumin designated comparison method, whereas 4 VITROS (Ortho Clinical Diagnostics, Rochester, New York) peer groups differed by -0.29 to -0.37 g/dL (15 of 21 differences [71%] had P < .001). For bromocresol purple albumin methods, the mean differences from the designated comparison method from 8 peer groups were 0.25 to 0.47 g/dL (all had P < .001). For total protein methods, 23 peer group mean values were -0.07 to 0.15 g/dL from the reference measurement procedure (12 of 24 [50%] had P < .001). The Beckman (Fullerton, California) Synchron LX20 had a bias of -0.30 g/dL (P <.001). The commutability of the conventional specimens was acceptable for 23 of 24 bromocresol green method-material combinations (96%) and 13 of 16 bromocresol purple albumin method-material combinations (81%). All (100%) of the 36 method-material combinations had acceptable commutability for total protein.
One (2.2%) of the instrument systems (Synchron) using bromocresol green and none (0%) of the instrument systems using bromocresol purple had satisfactory total-error performance for albumin measurement. Differences in results between bromocresol green and bromocresol purple methods precluded using common reference intervals for interpreting results for serum albumin. Eight of 9 instrument systems (86.5%) had satisfactory total-error performance for total protein measurement.
在 College of American Pathologists Comprehensive Chemistry Survey 中,同行组之间的血清成分检测结果存在差异。
评估血清白蛋白和总蛋白测量程序的性能,并评估常规检测标本的互换性。
除了 4 个常规检测标本外,还纳入了一个新鲜冷冻、非凝结的血清样本。新鲜冷冻、非凝结的血清样本是按照与天然临床样本具有互换性的方式制备的。
对于新鲜冷冻、非凝结的血清样本,17 个同行组的平均值与溴甲酚绿白蛋白指定比较方法相比,相差-0.07 至 0.32 g/dL,而 4 个 VITROS(Ortho Clinical Diagnostics,Rochester,纽约)同行组相差-0.29 至-0.37 g/dL(21 个差异中有 15 个[71%]差异有统计学意义(P <.001))。对于溴甲酚紫白蛋白方法,8 个同行组与指定比较方法的平均差异为 0.25 至 0.47 g/dL(均差异有统计学意义(P <.001))。对于总蛋白方法,23 个同行组的平均值与参考测量程序相比相差-0.07 至 0.15 g/dL(24 个中的 12 个[50%]差异有统计学意义(P <.001))。贝克曼(加利福尼亚州富勒顿)同步 LX20 有-0.30 g/dL 的偏倚(P <.001)。24 个溴甲酚绿方法-材料组合中的 23 个(96%)和 16 个溴甲酚紫白蛋白方法-材料组合中的 13 个(81%)的常规标本具有可接受的互换性。36 个方法-材料组合中的所有(100%)都具有总蛋白可接受的互换性。
使用溴甲酚绿的仪器系统之一(Synchron)(2.2%)和使用溴甲酚紫的仪器系统均未(0%)对白蛋白测量具有令人满意的总误差性能。溴甲酚绿和溴甲酚紫方法之间的结果差异排除了使用共同的参考区间来解释血清白蛋白结果的可能性。9 个仪器系统中的 8 个(86.5%)对总蛋白测量具有令人满意的总误差性能。